| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | EVP, Chief Legal Officer | Common Stock | 5,132 | $951,062 | $185.32 | 05 Aug 2021 | Direct |
| ALNYLAM PHARMACEUTICALS, INC. | EVP, Chief Legal Officer | Common Stock | 434 | $80,429 | $185.32 | 05 Aug 2021 | by Managed Account |
| Immuneering Corp | Director | Stock Option | 33,350 | 13 Jun 2025 | Direct | ||
| PepGen Inc. | Director | Stock Option (Right to Buy) | 16,000 | 04 Jun 2025 | Direct | ||
| ALNYLAM PHARMACEUTICALS, INC. | EVP, Chief Legal Officer | Performance Stock Option 2015 (right to buy) | 11,876 | 05 Aug 2021 | Direct | ||
| ALNYLAM PHARMACEUTICALS, INC. | EVP, Chief Legal Officer | Stock Option (right to buy) | 1,124 | 05 Aug 2021 | Direct | ||
| Imago BioSciences, Inc. | Director | Stock Option (Right to Buy) | 0 | 11 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IMRX | Immuneering Corp | 13 Jun 2025 | 1 | $0 | 4 | Director | 16 Jun 2025, 09:09 |
| PEPG | PepGen Inc. | 04 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 06:51 |
| IMRX | Immuneering Corp | 01 Jan 2025 | 1 | $0 | 4 | Director | 02 Jan 2025, 16:06 |
| PEPG | PepGen Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 16:10 |
| IMRX | Immuneering Corp | 12 Jun 2024 | 1 | $0 | 4 | Director | 13 Jun 2024, 16:22 |
| IMRX | Immuneering Corp | 01 Jan 2024 | 1 | $0 | 4 | Director | 02 Jan 2024, 16:31 |
| PEPG | PepGen Inc. | 22 Jun 2023 | 1 | $0 | 4 | Director | 26 Jun 2023, 16:13 |
| IMRX | Immuneering Corp | 14 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 16:44 |
| IMGO | Imago BioSciences, Inc. | 11 Jan 2023 | 2 | $0 | 4 | Director | 11 Jan 2023, 15:23 |
| IMRX | Immuneering Corp | 21 Jun 2022 | 1 | $0 | 4 | Director | 23 Jun 2022, 16:59 |
| IMGO | Imago BioSciences, Inc. | 01 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 16:42 |
| IMRX | Immuneering Corp | 16 May 2022 | 1 | $35,000 | 4 | Director | 17 May 2022, 17:15 |
| PEPG | PepGen Inc. | 06 May 2022 | 1 | $49,992 | 4 | Director | 19 Jan 2023, 16:17 |
| PEPG | PepGen Inc. | 06 May 2022 | 1 | $0 | 4 | Director | 10 May 2022, 18:50 |
| PEPG | PepGen Inc. | 05 May 2022 | 0 | $0 | 3 | Director | 05 May 2022, 20:30 |
| IMGO | Imago BioSciences, Inc. | 17 Nov 2021 | 1 | $0 | 4 | Director | 19 Nov 2021, 16:59 |
| IMGO | Imago BioSciences, Inc. | 17 Nov 2021 | 0 | $0 | 3 | Director | 19 Nov 2021, 16:58 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 05 Aug 2021 | 5 | -$1,000,000 | 4 | EVP, Chief Legal Officer | 09 Aug 2021, 16:09 |
| IMRX | Immuneering Corp | 03 Aug 2021 | 1 | $105,000 | 4 | Director | 04 Aug 2021, 06:06 |
| IMRX | Immuneering Corp | 29 Jul 2021 | 0 | $0 | 3 | Director | 29 Jul 2021, 20:53 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 12 Jul 2021 | 6 | -$620,328 | 4 | EVP, Chief Legal Officer | 14 Jul 2021, 16:58 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 09 Jun 2021 | 1 | -$267,036 | 4 | EVP, Chief Legal Officer | 11 Jun 2021, 16:13 |